MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast cancer

Role of molecular diagnostics in prostate cancer

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA

Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history

BCMA: A new biomarker for multiple myeloma

Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma

Public policy in the fight against non-communicable diseases

HPV: The global threat of vaccination hesitancy

Symptomatic control in palliative medicine

Cancer control in Africa - Special Issue

Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer

An overview of the latest advances in gastric cancer